Cetuximab Compared to Mitomycin-C and 5-Fluorouracil for Locally Advanced Squamous Cell Carcinomas of the Head and Neck

NCT02015650 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Low Recruitment rate

Conditions

Head and Neck Neoplasms

Interventions

DRUG: Cetuximab
DRUG: Mitomycin-C/ 5-Fluorouracil

Sponsor

Medical University Innsbruck